Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate
Jilin Aodong Pharmaceutical Group Co Ltd cash flow reinvestment rate. Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥25.80 Million (capex CN¥25.80 Million ) from operating cash flow of CN¥112.12 Million. See financial flexibility index of Jilin Aodong Pharmaceutical Group Co Ltd to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jilin Aodong Pharmaceutical Group Co Ltd (1999–2025)
Cash flow reinvestment rate of Jilin Aodong Pharmaceutical Group Co Ltd from 1999 to 2025. Historical reinvestment intensity for Jilin Aodong Pharmaceutical Group Co Ltd across 26 annual periods. Explore Jilin Aodong Pharmaceutical Group Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate by Year (1999–2025)
Jilin Aodong Pharmaceutical Group Co Ltd cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Jilin Aodong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Jilin Aodong Pharmaceutical Group Co Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.17x | CN¥862.15 Million | CN¥272.26 Million | CN¥128.45 Million | ▼ -80.8% |
| 2024 | 16.48x | CN¥980.49 Million | CN¥59.48 Million | CN¥273.98 Million | ▼ -5.2% |
| 2023 | 17.38x | CN¥1.18 Billion | CN¥68.06 Million | CN¥419.52 Million | ▲ +432.8% |
| 2022 | 3.26x | CN¥1.38 Billion | CN¥423.86 Million | CN¥270.97 Million | ▼ -24.0% |
| 2021 | 4.29x | CN¥1.39 Billion | CN¥324.85 Million | CN¥313.30 Million | ▲ +417.1% |
| 2020 | 0.83x | CN¥323.95 Million | CN¥390.41 Million | CN¥227.38 Million | ▼ -4.3% |
| 2019 | 0.87x | CN¥328.96 Million | CN¥379.46 Million | CN¥222.40 Million | ▼ -87.2% |
| 2018 | 6.76x | CN¥2.35 Billion | CN¥347.64 Million | CN¥245.30 Million | ▲ +217.9% |
| 2017 | 2.13x | CN¥545.48 Million | CN¥256.49 Million | CN¥83.93 Million | ▼ -3.8% |
| 2016 | 2.21x | CN¥738.12 Million | CN¥333.81 Million | CN¥158.03 Million | ▼ -40.3% |
| 2015 | 3.70x | CN¥1.44 Billion | CN¥388.03 Million | CN¥334.11 Million | ▲ +166.0% |
| 2014 | 1.39x | CN¥402.01 Million | CN¥288.83 Million | CN¥402.01 Million | ▼ -9.4% |
| 2013 | 1.54x | CN¥309.01 Million | CN¥201.22 Million | CN¥309.01 Million | ▲ +28.0% |
| 2012 | 1.20x | CN¥326.80 Million | CN¥272.40 Million | CN¥326.80 Million | ▼ -71.6% |
| 2011 | 4.23x | CN¥457.72 Million | CN¥108.30 Million | CN¥457.72 Million | ▲ +384.4% |
| 2010 | 0.87x | CN¥152.00 Million | CN¥174.22 Million | CN¥152.00 Million | ▲ +409.0% |
| 2009 | 0.17x | CN¥36.51 Million | CN¥213.03 Million | CN¥36.51 Million | ▲ +27.8% |
| 2008 | 0.13x | CN¥31.52 Million | CN¥235.03 Million | CN¥31.52 Million | ▲ +31.5% |
| 2007 | 0.10x | CN¥39.24 Million | CN¥384.69 Million | CN¥39.24 Million | ▼ -66.3% |
| 2006 | 0.30x | CN¥56.87 Million | CN¥187.99 Million | CN¥56.87 Million | ▼ -26.0% |
| 2005 | 0.41x | CN¥55.68 Million | CN¥136.26 Million | CN¥55.68 Million | ▲ +93.4% |
| 2004 | 0.21x | CN¥46.19 Million | CN¥218.53 Million | CN¥46.19 Million | ▼ -66.0% |
| 2003 | 0.62x | CN¥91.89 Million | CN¥147.65 Million | CN¥91.89 Million | ▼ -58.4% |
| 2001 | 1.49x | CN¥207.37 Million | CN¥138.76 Million | CN¥207.37 Million | ▼ -29.8% |
| 2000 | 2.13x | CN¥163.90 Million | CN¥77.04 Million | CN¥163.90 Million | ▲ +232.4% |
| 1999 | 0.64x | CN¥70.52 Million | CN¥110.18 Million | CN¥70.52 Million | — |